3H]chloramphenicol metabolism in human volunteer: oxamic acid as a new major metabolite
Corpet, D.E.; Bories, G.F.
Drug Metabolism and Disposition the Biological Fate of Chemicals 15(6): 925-927
1987
ISSN/ISBN: 0090-9556 PMID: 2893723 Document Number: 290064
Document emailed within 1 workday
Related Documents
Vane, F.M.; Buggé, C.J. 1981: Identification of 4-oxo-13-cis-retinoic acid as the major metabolite of 13-cis-retinoic acid in human blood Drug Metabolism and Disposition: the Biological Fate of Chemicals 9(6): 515-520Lubawy, W.C.; Kostenbauder, H.B.; Stavchansky, S.A. 1974: Cross inhibition of drug metabolism by drug metabolites. Increase of zoxazolamine paralysis time by the major metabolite of diphenylhydantoin Research Communications in Chemical Pathology and Pharmacology 8(1): 75-82
Tan, L.; Yang, S.R.; Liu, X.Q.; Yuan, Y.S. 1995: Simultaneous determination of verapamil and its major metabolite in human plasma by high performance liquid chromatography Yao Xue Xue Bao 30(9): 689-693
Talseth, T.; Haegele, K.D.; McNay, J.L.; Skrdlant, H.B.; Clementi, W.A.; Shepherd, A.M. 1979: Pharmacokinetics and cardiovascular effects in rabbits of a major hydralazine metabolite, the hydralazine pyruvic-acid hydrazone Journal of Pharmacology and Experimental Therapeutics 211(3): 509-513
Büchi, G.H.; Müller, P.M.; Roebuck, B.D.; Wogan, G.N. 1974: Aflatoxin Q1: a major metabolite of aflatoxin B1 produced by human liver Research Communications in Chemical Pathology and Pharmacology 8(4): 585-592
Hirsch, R.E.; Lin, M.J.; Das, K.M. 1990: Estimation of 5-aminosalicylic acid and its metabolite in human serum by front-face fluorometry: a simple and sensitive method Journal of Laboratory and Clinical Medicine 116(1): 45-50
Lemoine, A.; Gautier, J.C.; Azoulay, D.; Kiffel, L.; Belloc, C.; Guengerich, F.P.; Maurel, P.; Beaune, P.; Leroux, J.P. 1993: Major pathway of imipramine metabolism is catalyzed by cytochromes P-450 1A2 and P-450 3A4 in human liver Molecular Pharmacology 43(5): 827-832
Greter, J.; Lindstedt, S.; Steen, G. 1983: 2,6-Dimethyloctanedioic acid--a metabolite of phytanic acid in Refsum's disease Clinical Chemistry 29(3): 434-437
Shirota, F.N.; Nagasawa, H.T.; Kwon, C.H.; DeMaster, E.G. 1984: N-acetylcyanamide, the major urinary metabolite of cyanamide in rat, rabbit, dog, and man Drug Metabolism and Disposition: the Biological Fate of Chemicals 12(3): 337-344
Wells, D.A.; Hawi, A.A.; Digenis, G.A. 1992: Isolation and identification of the major urinary metabolite of N-methylpyrrolidinone in the rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(1): 124-126
Kintz, P.; Mangin, P.; Lugnier, A.; Chaumont, A.J. 1989: Determination of dextromethorphan and its major metabolite dextrorphan by gas chromatography Annales de Biologie Clinique 47(4): 193-195
Ciaccio, P.J.; Duignan, D.B.; Halpert, J.R. 1987: Selective inactivation by chloramphenicol of the major phenobarbital-inducible isozyme of dog liver cytochrome P-450 Drug Metabolism and Disposition: the Biological Fate of Chemicals 15(6): 852-856
Porubek, D.J.; Grillo, M.P.; Baillie, T.A. 1989: The covalent binding to protein of valproic acid and its hepatotoxic metabolite, 2-n-propyl-4-pentenoic acid, in rats and in isolated rat hepatocytes Drug Metabolism and Disposition: the Biological Fate of Chemicals 17(2): 123-130
Moch, D.; Schewe, T.; Kühn, H.; Schmidt, D.; Buntrock, P. 1990: The linoleic acid metabolite 9DS-hydroxy-10,12(E,Z)-octadecadienoic acid is a strong proinflammatory mediator in an experimental wound healing model of the rat Biomedica Biochimica Acta 49(4): 201-207
Achari, R.; Drissel, D.; Hulse, J.D. 1986: Liquid-chromatographic analysis for esmolol and its major metabolite in urine Clinical Chemistry 32(2): 374-376
Tang, B.K.; Grant, D.M.; Kalow, W. 1983: Isolation and identification of 5-acetylamino-6-formylamino-3-methyluracil as a major metabolite of caffeine in man Drug Metabolism and Disposition: the Biological Fate of Chemicals 11(3): 218-220
Rodrigues, A.D.; Roberts, E.M.; Mulford, D.J.; Yao, Y.; Ouellet, D. 1997: Oxidative metabolism of clarithromycin in the presence of human liver microsomes. Major role for the cytochrome P4503A (CYP3A) subfamily Drug Metabolism and Disposition: the Biological Fate of Chemicals 25(5): 623-630
Paroni, R.; Del Puppo, M.; Borghi, C.; Sirtori, C.R.; Galli Kienle, M. 1989: Pharmacokinetics of ribavirin and urinary excretion of the major metabolite 1,2,4-triazole-3-carboxamide in normal volunteers International Journal of Clinical Pharmacology Therapy and Toxicology 27(6): 302-307
Yamada, N.; Arai, Y.; Funayama, K.; Kadowaki, S.; Takahashi, K.; Umezu, K. 1995: Effect of a major metabolite of the antiallergic drug repirinast on phosphodiesterase and adenylate cyclase activities Arzneimittel-Forschung 45(1): 33-35
Ostrovskaia, R.U.; Liapina, L.A.; Pastorova, V.E.; Mirzoev, T.K.; Gudasheva, T.A.; Seredenin, S.B.; Ashmarin, I.P. 2002: Multicomponent antithrombotic effect of the neuroprotective prolyl dipeptide GVS-111 and its major metabolite cyclo-L-prolylglycine Eksperimental'naia i Klinicheskaia Farmakologiia 65(2): 34-37